PD 169316

CAS No. 152121-53-4

PD 169316( PD169316 | PD-169316 )

Catalog No. M12125 CAS No. 152121-53-4

A potent, selective p38 MAPK inhibitor with IC50 of 89 nM.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 43 In Stock
10MG 71 In Stock
25MG 125 In Stock
50MG 203 In Stock
100MG 357 In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    PD 169316
  • Note
    Research use only, not for human use.
  • Brief Description
    A potent, selective p38 MAPK inhibitor with IC50 of 89 nM.
  • Description
    A potent, selective p38 MAPK inhibitor with IC50 of 89 nM; displays >100-fold selectivity over ERK, PKA, PKCα; prevent p38 phosphorylation while promotes the phosphorylation of the pro-survival SAPK/JNK and ERK.
  • In Vitro
    PD169316 (10 μM) inhibits TGFβ and Activin A, but not BMP4 signaling in CaOV3 cells. PD169316 (0.2-20 μM) inhibits TGFβ-induced Smad2 nuclear translocation, Smad7 mRNA induction, and reporter gene activity in CaOV3 cells. PD169316 (10 μM) shows a significantly increased rate of proliferation in Nestin knockdown cells, and can rescue the effect of Nestin knockdown on cell viability in the absence of EGF. PD169316 significantly inhibits p38 MAP kinase activity with no significant change in ERK activity in PC12 cells. PD169316 (10 μM) blocks apoptosis induced by trophic factor withdrawal in differentiated PC12 cells.PD169316 (10 μM, 30 min) selectively inhibits the kinase activity of the phosphorylated p38 without hindering upstream kinases to phosphorylate p38. Increased phospho p-38 levels in the presence of PD169316 are most likely due to blockade of negative feedback loop of dephosphorylation of p38 MAPK by MAPK phosphatases. Western Blot Analysis Cell Line:Ishikawa PRB or PRA cells.Concentration:10 μM.Incubation Time:30 min.Result:Did not inhibit MEKK1-induced p38 phosphorylation.
  • In Vivo
    PD169316 (1 mg/kg, intramuscular injection every day for 14 consecutive days) shows antiviral activity in a suckling mouse model. Animal Model:EV71-challenged suckling mouse model (7-day-old Kunming mice).Dosage:1 mg/kg. Administration:Intramuscular injection every day for 14 consecutive days.Result:Showed antiviral activity.
  • Synonyms
    PD169316 | PD-169316
  • Pathway
    MAPK/ERK Signaling
  • Target
    p38 MAPK
  • Recptor
    p38
  • Research Area
    Inflammation/Immunology
  • Indication
    ——

Chemical Information

  • CAS Number
    152121-53-4
  • Formula Weight
    360.3412
  • Molecular Formula
    C20H13FN4O2
  • Purity
    >98% (HPLC)
  • Solubility
    10 mM in DMSO
  • SMILES
    O=[N+](C1=CC=C(C2=NC(C3=CC=NC=C3)=C(C4=CC=C(F)C=C4)N2)C=C1)[O-]
  • Chemical Name
    Pyridine, 4-[4-(4-fluorophenyl)-2-(4-nitrophenyl)-1H-imidazol-5-yl]-

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Gallagher TF, et al. Bioorg Med Chem. 1997 Jan;5(1):49-64. 2. Krishnamoorthy M, et al. J Biochem. 2009 Feb;145(2):177-84. 3. Kozawa O, et al. Cell Signal. 2000 Jul;12(7):447-50.
molnova catalog
related products
  • EO-1606

    EO-1606 is a p38MAP kinase inhibitor with anti-inflammatory activity and may be used in studies of Alzheimer;s disease and dermatitis.

  • Nek2-IN-5

    Nek2-IN-5 (NCL00017509) is a potent and selective inhibitor of NIMA-related kinase 2 (Nek2).

  • UR13870

    UR-13870 (Org 48762-0) is an orally active and selective inhibitor of p38 mitogen-activated protein kinase (MAPK), which prevents bone damage in collagen-induced arthritis in mice.